RICHELE MACHT: Open Payments
NPI 1396168514 · ALMA, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$412 in 14 payments from 8 companies in 2025. Trend: 2023 $184 · 2024 $115 · 2025 $412
Food & beverage: $254Education: $158
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $174 |
| Novo Nordisk Inc | 4 | $87 |
| Lilly USA, LLC | 2 | $36 |
| CeQur Corporation | 1 | $33 |
| Abbott Laboratories | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| PFIZER INC. | 1 | $20 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
Products named: Ozempic, MOUNJARO, CeQur Simplicity, FREESTYLE LIBRE 3, BREZTRI, PREVNAR 20, ELIQUIS, Veozah.
Industry payments across MI — which companies pay providers there.
